Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Goldline Pharmaceutical: Disclosure Under Regulation 29 (2) Of Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
News Announcement

Goldline Pharmaceutical: Disclosure Under Regulation 29 (2) Of Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011

23-Jun-2026 Follow Value Research Online on Google download pdfDownload PDF Goldline Pharmaceutical

Disclosure under regulation 29 (2) of SEBI (SAST) Regulations 2011

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan